Lind Global Fund II LP 13D and 13G filings for Vallon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 4:30 pm Sale |
2022-12-31 | 13G | Vallon Pharmaceuticals, Inc. VLON |
Lind Global Fund II LP | 250 0.100% |
-35,900 (-99.31%) |
Filing |
| 2022-05-23 5:00 pm Purchase |
2022-05-17 | 13G | Vallon Pharmaceuticals, Inc. VLON |
Lind Global Fund II LP | 36,150 9.900% |
36,150 (New Position) |
Filing |